Mortality Prediction Using Trauma Scores
Launched by AL-NAHRAIN UNIVERSITY · Nov 25, 2024
Trial Information
Current as of September 08, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Mortality Prediction Using Trauma Scores," is studying different scoring systems that help doctors predict the chances of survival for patients who have experienced trauma, such as injuries from accidents. The researchers want to find out which of these scoring systems—called the Injury Severity Score (ISS), New Injury Severity Score (NISS), Revised Trauma Score (RTS), and Trauma and Injury Severity Score (TRISS)—is the most accurate in predicting whether a patient will survive their injuries. They will also look at whether certain groups of patients benefit more from one scoring system over the others.
To participate in this trial, individuals must be trauma patients who are admitted to the emergency room and have enough information about their injuries to calculate the scoring systems. Participants will be assessed with all four scoring methods right after they arrive at the hospital, and their health outcomes will be monitored throughout their stay. This includes tracking how long they are in the hospital and whether they are admitted to the intensive care unit (ICU). It’s important to note that the trial is open to all adult trauma patients, but it does not include those under 18, pregnant women, or patients with other serious health conditions that are not related to trauma. Additionally, participation requires informed consent, meaning patients or their legal guardians must agree to take part in the study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Trauma patients admitted to the emergency room (ER).
- • Documented injury data sufficient to calculate both the New Injury Severity Score (NISS) and the Injury Severity Score (ISS).
- • Trauma scores (ISS, NISS, Revised Trauma Score \[RTS\], and Trauma and Injury Severity Score \[TRISS\]) calculated within 12 hour of arrival to ensure timely predictions.
- • Informed consent provided by the patient or a legal guardian in cases of incapacity.
- Exclusion Criteria:
- • Under 18 years of age and pregnant women, due to differences in trauma management and scoring applicability.
- • Non-trauma cases, including patients with terminal illnesses or severe cognitive impairments, to maintain focus on trauma outcomes.
- • Incomplete trauma scoring, missing or incomplete medical records, and
- • patients not treated in the trauma or emergency department.
- • Patients who refuse participation or withdraw consent to ensure ethical participation.
- • Transferred patients and those enrolled in other research studies that could interfere with trauma scoring.
About Al Nahrain University
Al-Nahrain University is a leading academic institution dedicated to advancing medical research and education in Iraq. With a focus on innovative clinical trials, the university aims to enhance healthcare outcomes through rigorous scientific investigation and collaboration with local and international partners. Its commitment to ethical research practices and adherence to regulatory standards positions Al-Nahrain University as a pivotal contributor to the development of new therapeutic interventions and the overall improvement of public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baghdad, , Iraq
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported